NeuMoDx 96 and 288 Molecular Systems
For high-throughput, automated PCR applications
NeuMoDx Molecular, Inc. was acquired by QIAGEN on September 17, 2020. As a result, starting on November 1, 2020, orders and support on NeuMoDx products will change to the following guidance.
For US customers:
For non-US customers, please contact your local affiliate.
Click here to return to NeuMoDx.com
fragment fix placeholder